These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9708935)

  • 1. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.
    Chang TC; Lai CH; Tseng CJ; Hsueh S; Huang KG; Chou HH
    Cancer; 1998 Aug; 83(4):712-8. PubMed ID: 9708935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
    Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
    Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide.
    Morris M; Gershenson DM; Eifel P; Silva EG; Mitchell MF; Burke TW; Wharton JT
    Gynecol Oncol; 1992 Oct; 47(1):62-5. PubMed ID: 1330847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
    Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
    Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
    Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC
    Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
    Yin ZM; Yu AJ; Wu MJ; Fang J; Liu LF; Zhu JQ; Yu H
    Eur J Gynaecol Oncol; 2015; 36(3):326-9. PubMed ID: 26189262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen.
    Tokunaga H; Nagase S; Yoshinaga K; Tanaka S; Nagai T; Kurosawa H; Kaiho-Sakuma M; Toyoshima M; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Tohoku J Exp Med; 2013 Jan; 229(1):75-81. PubMed ID: 23269283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of early stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy.
    Linghu H; Xu XR; Mei YY; Tang JY; Tang LD; Sun T
    Chin Med Sci J; 2004 Jun; 19(2):116-9. PubMed ID: 15250247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma.
    Lai CH; Lin TS; Soong YK; Chen HF
    Gynecol Oncol; 1989 Nov; 35(2):193-8. PubMed ID: 2478428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
    Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
    Yuan L; Jiang H; Lu Y; Guo SW; Liu X
    Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy in stage IB neuroendocrine small cell carcinoma of the cervix.
    Abulafia O; Sherer DM
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):740-4. PubMed ID: 7572111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor.
    Kim DS; Moon H; Kim KT; Hwang YY; Cho SH; Kim SR
    Gynecol Oncol; 1989 May; 33(2):225-30. PubMed ID: 2467848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).
    de Campos ES; Menasce LP; Radford J; Harris M; Thatcher N
    Cancer; 1994 Jan; 73(2):470-5. PubMed ID: 8293415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.